Jey K Chung, MD
Pulmonary Disease · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 19 years
- Boston University School of Medicine, 2007
Offices
2 locations · San Francisco Critical Care Med Group Inc · Sutter Bay Medical Foundation
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chung’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A107612 · Current
Licensed to practise in California · since 2009 · expires 2027-03-31 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$89,879
Medicare paid this office $89,879 for 328 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 114 | $37,833 | $189 |
| Return visit (30+ min) | 61 | $10,065 | $123 |
| New patient visit (45+ min) | 53 | $8,607 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $4,301 | $73 |
| Short return visit (20+ min) | 45 | $4,072 | $87 |
See all 12 services
| Critical care, first 30-74 minutes | 114 | $37,833 | $189 |
| Return visit (30+ min) | 61 | $10,065 | $123 |
| New patient visit (45+ min) | 53 | $8,607 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $4,301 | $73 |
| Short return visit (20+ min) | 45 | $4,072 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,249 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,754 | $162 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 14 | $2,356 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,309 | $115 |
| New patient visit (30+ min) | 11 | $1,039 | $94 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 14 | $971 | $69 |
| Ultrasonic guidance for blood vessel access | 15 | $174 | $12 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 20 | 19 | 24 | 17 | 23 | 14 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | – | 12 | 16 | 11 | 13 | – |
| Insertion of artery tube for blood sampling or infusion through skin | 17 | 13 | 18 | – | – | – |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | – | – | 19 | 11 | 12 | – |
| Emergent insertion of breathing tube into windpipe using an endoscope | 11 | 13 | 16 | – | – | – |
| Biopsy of lobe of lung using an endoscope, 1 lobe | – | – | 18 | – | 13 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
328 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 15% · Women 50% · Also on Medicaid 43% · Health risk score 2.25. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · COPD 45% · Diabetes 42% · Coronary heart disease 42% · Chronic kidney disease 42% · Heart failure 39% · Atrial fibrillation 38% · Cancer 27% · Depression 25% · Stroke 16% · Dementia 15%.
The office billed $227,578, Medicare allowed $114,546 and paid $89,879; for 683 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 328 | 683 | 75 | 2.25 | $227,578 | $89,879 |
| 2023 | 304 | 739 | 74 | 2.49 | $251,499 | $92,840 |
| 2022 | 323 | 760 | 74 | 2.27 | $258,239 | $95,917 |
| 2021 | 359 | 974 | 74 | 2.46 | $309,643 | $115,518 |
| 2020 | 353 | 975 | 72 | 2.81 | $302,856 | $116,492 |
| 2019 | 373 | 921 | 73 | 2.77 | $304,964 | $111,887 |
| 2018 | 362 | 890 | 71 | 2.57 | $311,978 | $115,187 |
| 2017 | 343 | 811 | 72 | 2.84 | $265,210 | $99,894 |
| 2016 | 377 | 915 | 73 | 2.56 | $318,993 | $121,463 |
| 2015 | 105 | 216 | 72 | 2.65 | $83,867 | $32,494 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Critical care, first 30-74 minutes | 115 | $42,079 | $184 |
| Return visit (30+ min) | 49 | $8,121 | $118 |
| New patient visit (45+ min) | 41 | $5,787 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $5,447 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $4,760 | $71 |
| Short return visit (20+ min) | 47 | $4,589 | $82 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 23 | $3,460 | $150 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,024 | $156 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 12 | $1,788 | $149 |
| New patient visit (30+ min) | 13 | $1,169 | $90 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 13 | $1,023 | $79 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 13 | $829 | $64 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 13 | $751 | $58 |
2022: 14 services
| Critical care, first 30-74 minutes | 129 | $51,113 | $187 |
| Short return visit (20+ min) | 59 | $5,800 | $74 |
| Return visit (30+ min) | 35 | $4,329 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $4,295 | $62 |
| New patient visit (45+ min) | 26 | $3,848 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $3,553 | $89 |
| New patient visit (30+ min) | 30 | $2,641 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,509 | $119 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 17 | $2,434 | $143 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 11 | $1,645 | $150 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 14 | $1,020 | $73 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $842 | $77 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 11 | $648 | $59 |
| Ultrasonic guidance for blood vessel access | 14 | $169 | $12 |
2021: 22 services
| Critical care, first 30-74 minutes | 137 | $57,878 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $7,294 | $92 |
| New patient visit (45+ min) | 37 | $5,377 | $145 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 23 | $3,969 | $165 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,938 | $179 |
| Short return visit (20+ min) | 47 | $3,928 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $3,789 | $64 |
| Return visit (30+ min) | 22 | $3,057 | $113 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $2,701 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,699 | $117 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 19 | $2,424 | $128 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 16 | $1,958 | $122 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,737 | $116 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 18 | $1,473 | $82 |
| New patient visit (30+ min) | 17 | $1,466 | $86 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 17 | $1,457 | $86 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 16 | $957 | $60 |
| Insertion of artery tube for blood sampling or infusion through skin | 18 | $695 | $39 |
| Test to determine lung volumes using sensors | 24 | $262 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 23 | $215 | $9 |
| Test to examine how well the lungs exchange gases | 26 | $210 | $8 |
| Ultrasonic guidance for blood vessel access | 11 | $135 | $11 |
2020: 19 services
| Critical care, first 30-74 minutes | 150 | $62,034 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $9,453 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,742 | $179 |
| Short return visit (20+ min) | 36 | $4,076 | $66 |
| New patient visit (45+ min) | 27 | $3,803 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $3,448 | $66 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 19 | $3,204 | $169 |
| Return visit (30+ min) | 24 | $2,883 | $93 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $2,034 | $73 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 13 | $1,642 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,634 | $126 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 20 | $962 | $48 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 12 | $742 | $62 |
| Insertion of artery tube for blood sampling or infusion through skin | 13 | $515 | $40 |
| Test for exercise-induced lung stress | 18 | $377 | $21 |
| Test to determine lung volumes using sensors | 27 | $307 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $302 | $12 |
| Test to examine how well the lungs exchange gases | 27 | $236 | $8 |
| Ultrasonic guidance for blood vessel access | 15 | $196 | $13 |
2019: 14 services
| Critical care, first 30-74 minutes | 170 | $60,224 | $192 |
| Short return visit (20+ min) | 60 | $7,239 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,443 | $179 |
| New patient visit (45+ min) | 41 | $5,299 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $5,290 | $64 |
| Return visit (30+ min) | 32 | $4,470 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,955 | $90 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 20 | $3,550 | $178 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 11 | $1,342 | $122 |
| Insertion of artery tube for blood sampling or infusion through skin | 16 | $660 | $39 |
| Test to determine lung volumes using sensors | 14 | $143 | $10 |
| Ultrasonic guidance for blood vessel access | 11 | $140 | $13 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 11 | $129 | $12 |
| Test to examine how well the lungs exchange gases | 15 | $114 | $8 |
2018: 14 services
| Critical care, first 30-74 minutes | 183 | $75,970 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $5,562 | $64 |
| New patient visit (45+ min) | 39 | $5,219 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $5,003 | $93 |
| Return visit (30+ min) | 20 | $3,297 | $100 |
| Short return visit (20+ min) | 38 | $2,941 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,874 | $180 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 13 | $2,273 | $175 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,814 | $113 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $257 | $12 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 13 | $233 | $18 |
| Test to determine lung volumes using sensors | 19 | $209 | $11 |
| Test to examine how well the lungs exchange gases | 19 | $154 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $120 | $11 |
2017: 13 services
| Critical care, first 30-74 minutes | 184 | $62,650 | $196 |
| New patient visit (45+ min) | 38 | $5,774 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $4,847 | $65 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 20 | $3,888 | $185 |
| Return visit (30+ min) | 28 | $3,849 | $92 |
| Short return visit (20+ min) | 37 | $2,907 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,801 | $122 |
| Insertion of artery tube for blood sampling or infusion through skin | 13 | $623 | $44 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 11 | $577 | $52 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 26 | $317 | $12 |
| Test to determine lung volumes using sensors | 26 | $287 | $11 |
| Test to examine how well the lungs exchange gases | 27 | $221 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $152 | $11 |
2016: 13 services
| Critical care, first 30-74 minutes | 218 | $80,844 | $196 |
| New patient visit (45+ min) | 52 | $7,615 | $146 |
| Short return visit (20+ min) | 46 | $3,833 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $3,040 | $65 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 14 | $2,953 | $211 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,690 | $122 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 22 | $2,348 | $107 |
| Return visit (30+ min) | 17 | $2,143 | $102 |
| Insertion of artery tube for blood sampling or infusion through skin | 14 | $626 | $45 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $586 | $37 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 35 | $390 | $11 |
| Test to determine lung volumes using sensors | 34 | $365 | $11 |
| Test to examine how well the lungs exchange gases | 36 | $288 | $8 |
2015: 2 services
| Critical care, first 30-74 minutes | 72 | $24,535 | $198 |
| New patient visit (45+ min) | 12 | $1,854 | $155 |
Medicaid work
$13,659 in 2024
Medicaid paid $13,659 for 104 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 104 | $13,659 |
| 2024 | 104 | 1 | 17 | $13,659 |
| 2023 | 137 | 1 | 25 | $18,952 |
| 2022 | 38 | 1 | 21 | $2,566 |
| 2021 | 156 | 1 | 16 | $17,250 |
| 2020 | 91 | 1 | 12 | $11,226 |
| 2019 | 81 | 1 | 15 | $8,981 |
| 2018 | 151 | 1 | 25 | $13,787 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 137 | $18,952 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 38 | $2,566 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 156 | $17,250 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 91 | $11,226 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 81 | $8,981 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 151 | $13,787 |
Drugs they prescribed that Part D paid
$105,472
Pharmacies billed $105,472 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 223) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
0 generic and 175 brand-name prescriptions · $105,472 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 82 | $69,564 | $848 |
| Spiriva Respimat | 11 | $5,589 | $508 |
| Advair Hfa | 11 | $3,278 | $298 |
| Albuterol Sulfate Hfa | 28 | $871 | $31 |
| Ventolin Hfa | 11 | $601 | $55 |
Year by year
| 2024 | 223 | 62 | 0% (0) | 78% | $105,472 |
| 2023 | 165 | 45 | 0% (0) | 81% | $121,789 |
| 2022 | 82 | 25 | 0% (0) | 85% | $50,342 |
| 2021 | 101 | 30 | 0% (0) | 77% | $46,680 |
| 2020 | 112 | 34 | None | 79% | $71,491 |
| 2019 | 134 | 36 | 0% (0) | 84% | $159,142 |
| 2018 | 140 | 45 | 0% (0) | 84% | $66,891 |
| 2017 | 151 | 45 | None | 67% | $53,233 |
| 2016 | 65 | 27 | None | 74% | $17,744 |
| 2015 | 46 | 13 | None | 33% | $4,788 |
| 2014 | 12 | None | 0% (0) | None | $689 |
| 2013 | 17 | None | 0% (0) | 71% | $3,103 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Nucala | 13 | $46,950 | $3,612 |
| Trelegy Ellipta | 27 | $27,656 | $1,024 |
| Symbicort | 27 | $16,681 | $618 |
| Spiriva Respimat | 13 | $7,419 | $571 |
| Albuterol Sulfate Hfa | 22 | $758 | $34 |
| Ventolin Hfa | 13 | $729 | $56 |
2022: 1 drug
| Trelegy Ellipta | 19 | $14,057 | $740 |
2021: 1 drug
| Breo Ellipta | 22 | $12,425 | $565 |
2020: 2 drugs
| Breo Ellipta | 25 | $13,874 | $555 |
| Ventolin Hfa | 12 | $1,376 | $115 |
2019: 1 drug
| Breo Ellipta | 22 | $7,932 | $361 |
2018: 5 drugs
| Xolair | 11 | $12,165 | $1,106 |
| Advair Diskus | 20 | $10,767 | $538 |
| Spiriva Respimat | 13 | $9,172 | $706 |
| Breo Ellipta | 20 | $7,702 | $385 |
| Incruse Ellipta | 17 | $6,893 | $405 |
2017: 5 drugs
| Xolair | 11 | $11,536 | $1,049 |
| Advair Diskus | 21 | $10,146 | $483 |
| Spiriva | 11 | $8,491 | $772 |
| Spiriva Respimat | 15 | $7,249 | $483 |
| Montelukast | 14 | $282 | $20 |
2016: 1 drug
| Spiriva | 12 | $7,083 | $590 |
Money from drug and device companies
$10,708 in 2025
| 2025 | 3 | 11 | None | $10,708 |
| 2024 | 5 | 8 | $500 | $755 |
| 2023 | 3 | 13 | None | $12,984 |
| 2022 | 3 | 18 | None | $15,196 |
| 2021 | 3 | 10 | $500 | $5,096 |
| 2020 | 1 | 3 | None | $3,086 |
| 2019 | 9 | 15 | None | $418 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $10,611 | 9 payments
|
| Erbe USA | Vio Cryo Apc | $59 | 1 payment
|
| Pulmonx | Chartis Catheter | $38 | 1 payment
|
See all 11 published payments
| Intuitive Surgical | Meals · 2025-12-09 | Da Vinci Surgical System | $94 |
| Pulmonx | Meals · 2025-10-24 | Chartis Catheter | $38 |
| Intuitive Surgical | Education · 2025-08-20 | Da Vinci Surgical System | $4,000 |
| Intuitive Surgical | Meals · 2025-08-20 | Da Vinci Surgical System | $300 |
| Intuitive Surgical | Travel · 2025-05-02 | Da Vinci Surgical System | $36 |
| Intuitive Surgical | Education · 2025-04-25 | Da Vinci Surgical System | $2,000 |
| Intuitive Surgical | Meals · 2025-04-22 | Da Vinci Surgical System | $15 |
| Intuitive Surgical | Meals · 2025-03-18 | Da Vinci Surgical System | $16 |
| Erbe USA | Meals · 2025-02-25 | Vio Cryo Apc | $59 |
| Intuitive Surgical | Education · 2025-02-05 | Da Vinci Surgical System | $4,000 |
| Intuitive Surgical | Meals · 2025-02-05 | Da Vinci Surgical System | $150 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $755
| Intuitive Surgical | Da Vinci Surgical System | $608 | 2 payments
|
| Pulmonx | Chartis Catheter | $57 | 3 payments
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $43 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $33 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $13 | 1 payment
|
2023: $12,984
| Intuitive Surgical | Da Vinci Surgical System | $12,916 | 11 payments
|
| CoapTech | Puma System | $40 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $28 | 1 payment
|
2022: $15,196
| Intuitive Surgical | Da Vinci Surgical System | $15,143 | 15 payments
|
| Olympus America | Spiration Valve System | $36 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $18 | 1 payment
|
2021: $5,096
| Intuitive Surgical | Da Vinci Surgical System | $5,066 | 8 payments
|
| Electromed | Smartvest | $17 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $13 | 1 payment
|
2020: $3,086
| Intuitive Surgical | Da Vinci Surgical System | $3,086 | 3 payments
|
2019: $418
| Covidien LP | Superdimension | $79 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $72 | 1 payment
|
| Teva Pharmaceuticals USA | Cinqair | $69 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $59 | 3 payments
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $40 | 2 payments
|
| GlaxoSmithKline | Nucala | $35 | 2 payments
|
| Merck Sharp & Dohme | Zerbaxa | $29 | 2 payments
|
| Insmed | Arikayce | $19 | 1 payment
|
| Chiesi USA | Cleviprex | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1306071626
- Licence
- CA A107612California A107612: Current · expires 2027-03-31
- Trained
- Boston University School of Medicine, 2007 · 19 years ago
- Group
- San Francisco Critical Care Med Group Inc · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2351 Clay St, Ste 501, San Francisco, CA, 94115
- NPI first listed
- 2009-05-18
- NPI last updated
- 2015-11-02
This is when the NPI record was last certified, not a medical board exam.